This inventor holds 30 USPTO granted patents and 11 published patent applications, plus 3 CIPO patents and 13 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Dart Neuroscience, (Cayman) Ltd., Helicon Therapeutics, Inc., Dart Neuroscience, LLC. Active years: 2010-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kings Park, CA (US) (2010 - 2014)
- San Diego, CA (US) (2010 - 2022)
Company Filing History:
23 out of 41 
5 out of 10 
2 out of 16 Years Active: 2010-2022
Areas of Expertise:
Introduction
Alan P. Kaplan, based in Kings Park, California, is a prolific inventor with an impressive portfolio of 30 patents. His work primarily focuses on advancing therapeutic compounds and their potential applications in improving cognitive function and treating various neurological disorders.
Latest Patents
Alan's latest patents include groundbreaking work on substituted pyridine and pyrazine compounds as PDE4 inhibitors. This invention provides chemical entities that play a crucial role in various applications, including metabolic studies, imaging techniques, and therapies targeted at neurological and cognitive impairments. Additionally, he has created therapeutic isoxazole compounds that are inhibitors of monoamine oxidase B (MAO-B) enzyme function, indicating potential for improving cognitive function and addressing psychiatric disorders in animals.
Career Highlights
Throughout his career, Alan has been associated with notable organizations that contribute to neuroscience and therapeutic innovations, including Dart Neuroscience and Cayman Ltd. He has been involved in projects that bridge the gap between scientific research and therapeutic applications, showcasing his commitment to advancing medical science.
Collaborations
Alan Kaplan has collaborated with esteemed colleagues in his field, including Terence P. Keenan and Varsha Gupta. These partnerships highlight the collaborative nature of scientific research, bringing together diverse expertise to push the boundaries of invention and innovation.
Conclusion
With an impressive number of patents and a clear focus on improving cognitive health, Alan P. Kaplan exemplifies the spirit of innovation in therapeutic development. His contributions not only showcase individual talent and creativity but also emphasize the importance of collaboration and practical application in the field of neuroscience. His ongoing work continues to pave the way for advancements that hold promise for the treatment of neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile